Subsequent malignant neoplasms among children with Hodgkin lymphoma: a report from the Children’s Oncology Group

Survivors of Hodgkin lymphoma (HL) have an increased risk of subsequent malignant neoplasms (SMNs). Response-adapted treatment may decrease this risk by reducing exposure to therapy associated with SMN risk. The Children’s Oncology Group study AHOD0031 evaluated response-adapted therapy for children...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood
Main Authors: Giulino-Roth, Lisa, Pei, Qinglin, Buxton, Allen, Bush, Rizvan, Wu, Yue, Wolden, Suzanne L., Constine, Louis S., Kelly, Kara M., Schwartz, Cindy L., Friedman, Debra L.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2021
Assuntos:
Clinical Trials and Observations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7976513/
https://ncbi.nlm.nih.gov/pubmed/33512412
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2020007225
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados